Phathom Pharmaceuticals (PHAT) Insider Trading & Ownership $9.34 -0.11 (-1.16%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Phathom Pharmaceuticals (NASDAQ:PHAT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$30.82 M Get PHAT Insider Trade Alerts Want to know when executives and insiders are buying or selling Phathom Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PHAT Insider Buying and Selling by Quarter Ad WealthPressI hate to say I told you soLast month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…Follow this link right away. Phathom Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/15/2024Azmi NabulsiCOOSell10,901$11.72$127,759.72 7/15/2024Molly HendersonCFOSell4,325$11.72$50,689.00 7/15/2024Terrie CurranInsiderSell33,848$11.72$396,698.56 4/8/2024Molly HendersonCFOSell3,435$11.10$38,128.50 3/22/2024Terrie CurranInsiderSell16,851$9.11$153,512.61 1/24/2024Pharmaceutical Co Ltd TakedaMajor ShareholderSell3,703,703$8.10$29,999,994.30 1/19/2024Molly HendersonCFOSell6,307$7.75$48,879.25 (Data available from 1/1/2013 forward) PHAT Insider Trading Activity - Frequently Asked Questions Who is on Phathom Pharmaceuticals's Insider Roster? The list of insiders at Phathom Pharmaceuticals includes Asit Parikh, Azmi Nabulsi, Molly Henderson, Pharmaceutical Co Ltd Takeda, and Terrie Curran. Learn more on insiders at PHAT. What percentage of Phathom Pharmaceuticals stock is owned by insiders? 24.10% of Phathom Pharmaceuticals stock is owned by insiders. Learn more on PHAT's insider holdings. Which Phathom Pharmaceuticals insiders have been buying company stock? The following insiders have purchased PHAT shares in the last 24 months: Asit Parikh ($108,740.00), Azmi Nabulsi ($82,600.00), and Terrie Curran ($101,026.58). How much insider buying is happening at Phathom Pharmaceuticals? Insiders have purchased a total of 37,419 PHAT shares in the last 24 months for a total of $292,366.58 bought. Which Phathom Pharmaceuticals insiders have been selling company stock? The following insiders have sold PHAT shares in the last 24 months: Azmi Nabulsi ($127,759.72), Molly Henderson ($340,479.50), Pharmaceutical Co Ltd Takeda ($29,999,994.30), and Terrie Curran ($610,206.81). How much insider selling is happening at Phathom Pharmaceuticals? Insiders have sold a total of 3,808,660 Phathom Pharmaceuticals shares in the last 24 months for a total of $31,078,440.33 sold. Phathom Pharmaceuticals Key ExecutivesMs. Terrie J. Curran (Age 55)President, CEO & Director Compensation: $1.22M1 recent tradesMr. David A. Socks (Age 49)Co-Founder & Director Compensation: $54.17kDr. Azmi Nabulsi M.D. (Age 64)M.P.H., Co-Founder & COO Compensation: $888.9kMs. Molly Henderson CPA (Age 53)MBA, Chief Financial & Business Officer Compensation: $777.76k1 recent tradesDr. Aditya Kohli Ph.D. (Age 36)Co-Founder Compensation: $319.65kMr. Paul CocjaChief People OfficerMr. Tom HarrisChief Development Sciences OfficerDr. Eckhard Leifke M.D.Ph.D., Chief Medical OfficerMr. Martin J. GilliganChief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies ORIC Pharmaceuticals Insider Selling Nkarta Insider Selling Karyopharm Therapeutics Insider Selling Innoviva Insider Selling Arcutis Biotherapeutics Insider Selling BioXcel Therapeutics Insider Selling Supernus Pharmaceuticals Insider Selling Amneal Pharmaceuticals Insider Selling Zai Lab Insider Selling Catalyst Pharmaceuticals Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:PHAT) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phathom Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phathom Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
